CAR-T · Transplant · International Patient · 10 August 2026
Margarita's Journey: Overcoming Leukaemia Across Borders

Diagnosis
T-cell acute lymphoblastic leukaemia (T-ALL)
Home country
Russia
Prior treatment
Standard chemotherapy — failed to control the disease
Treatment at GHG
CAR-T cell therapy combined with haematopoietic stem cell transplantation
Outcome
Positive treatment response; safely discharged and returned home
Follow-up
Ongoing joint follow-up between the GHG clinical team and her doctors in Russia
Margarita was diagnosed with T-cell acute lymphoblastic leukaemia (T-ALL), an aggressive and highly complex blood cancer. After standard chemotherapy failed to control the disease, she came to GoBroad Healthcare Group (GHG) in China for advanced treatment.
The GHG team developed a precise plan combining CAR-T cell therapy with haematopoietic stem cell transplantation, helping Margarita achieve a positive treatment response.
Safely home, closely followed
Recently, she was safely discharged and returned to Russia for local follow-up care. The GHG clinical team remains in close communication with her doctors in Russia to monitor recovery, manage risks, and safeguard her long-term health.
Across borders, our shared goal remains the same: to protect life, provide hope, and stand by every patient throughout their journey.
Treatment timeline
- Before coming to ChinaDiagnosed with T-cell acute lymphoblastic leukaemia; standard chemotherapy failed to control the disease.
- Arrival at GHGMultidisciplinary assessment at GoBroad Healthcare Group; a combined CAR-T and transplant strategy was designed.
- CAR-T therapyCAR-T cell infusion delivered disease control and prepared her for transplant.
- TransplantHaematopoietic stem cell transplantation consolidated the response.
- August 2026Safely discharged and returned to Russia; joint follow-up between GHG and her local doctors continues.